ACGL
Price
$90.17
Change
-$0.13 (-0.14%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
34.59B
33 days until earnings call
INBX
Price
$14.92
Change
-$0.29 (-1.91%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
216.13M
60 days until earnings call
Interact to see
Advertisement

ACGL vs INBX

Header iconACGL vs INBX Comparison
Open Charts ACGL vs INBXBanner chart's image
Arch Capital Group
Price$90.17
Change-$0.13 (-0.14%)
Volume$19.82K
Capitalization34.59B
Inhibrx Biosciences
Price$14.92
Change-$0.29 (-1.91%)
Volume$530
Capitalization216.13M
ACGL vs INBX Comparison Chart in %
Loading...
ACGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACGL vs. INBX commentary
Jun 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACGL is a Hold and INBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 21, 2025
Stock price -- (ACGL: $90.30 vs. INBX: $15.21)
Brand notoriety: ACGL and INBX are both not notable
ACGL represents the Multi-Line Insurance, while INBX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACGL: 107% vs. INBX: 63%
Market capitalization -- ACGL: $34.59B vs. INBX: $220.18M
ACGL [@Multi-Line Insurance] is valued at $34.59B. INBX’s [@Biotechnology] market capitalization is $220.18M. The market cap for tickers in the [@Multi-Line Insurance] industry ranges from $634.15B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Multi-Line Insurance] industry is $21.11B. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACGL’s FA Score shows that 2 FA rating(s) are green whileINBX’s FA Score has 2 green FA rating(s).

  • ACGL’s FA Score: 2 green, 3 red.
  • INBX’s FA Score: 2 green, 3 red.
According to our system of comparison, INBX is a better buy in the long-term than ACGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACGL’s TA Score shows that 4 TA indicator(s) are bullish while INBX’s TA Score has 6 bullish TA indicator(s).

  • ACGL’s TA Score: 4 bullish, 5 bearish.
  • INBX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, INBX is a better buy in the short-term than ACGL.

Price Growth

ACGL (@Multi-Line Insurance) experienced а +1.02% price change this week, while INBX (@Biotechnology) price change was +3.61% for the same time period.

The average weekly price growth across all stocks in the @Multi-Line Insurance industry was -0.21%. For the same industry, the average monthly price growth was +2.12%, and the average quarterly price growth was +20.22%.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.02%. For the same industry, the average monthly price growth was +29.50%, and the average quarterly price growth was +16.11%.

Reported Earning Dates

ACGL is expected to report earnings on Jul 23, 2025.

INBX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Multi-Line Insurance (-0.21% weekly)

A multi-line insurance contract bundles together exposures to risk and covers them under a single contract. For providers of such policies, the bundle is a potential risk diversification strategy since their exposure gets spread over several factors, which helps them mitigate a financial burden if a catastrophic event were to occur. Other potential benefits include getting more premiums from including more than one type of insurance in a bundle, and getting a competitive edge by procuring multiple insurance contracts with a customer. Examples of companies in this industry are Berkshire Hathaway (which owns several insurance companies), Chubb Limited, American International Group, Inc. and Sun Life Financial Inc.

@Biotechnology (+11.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACGL($34.6B) has a higher market cap than INBX($216M). ACGL has higher P/E ratio than INBX: ACGL (7.94) vs INBX (0.13). INBX YTD gains are higher at: -1.234 vs. ACGL (-2.220). ACGL has more cash in the bank: 8.03B vs. INBX (217M). INBX has less debt than ACGL: INBX (107M) vs ACGL (2.73B). ACGL has higher revenues than INBX: ACGL (13.3B) vs INBX (200K).
ACGLINBXACGL / INBX
Capitalization34.6B216M16,019%
EBITDAN/A1.73B-
Gain YTD-2.220-1.234180%
P/E Ratio7.940.136,332%
Revenue13.3B200K6,650,000%
Total Cash8.03B217M3,699%
Total Debt2.73B107M2,548%
FUNDAMENTALS RATINGS
ACGL: Fundamental Ratings
ACGL
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACGLINBX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
51%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
42%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 19 days ago
64%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
51%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ACGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EKBDX14.090.04
+0.28%
Allspring Diversified Cap Bldr Adm
CSDGX15.000.02
+0.13%
Copeland SMID Cap Dividend Growth A
WHGOX12.000.01
+0.08%
Westwood Income Opportunity Ultra
ITHVX54.40-0.03
-0.06%
Hartford Capital Appreciation R6
WIREX19.39-0.02
-0.10%
Wireless

ACGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACGL has been closely correlated with ORI. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACGL jumps, then ORI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACGL
1D Price
Change %
ACGL100%
+0.17%
ORI - ACGL
73%
Closely correlated
+0.35%
AIG - ACGL
62%
Loosely correlated
+0.04%
HIG - ACGL
61%
Loosely correlated
-0.50%
FIHL - ACGL
52%
Loosely correlated
+0.44%
IGIC - ACGL
42%
Loosely correlated
+0.62%
More

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+4.04%
AXON - INBX
48%
Loosely correlated
-0.87%
AKESF - INBX
45%
Loosely correlated
N/A
IMNM - INBX
41%
Loosely correlated
-1.34%
SNTI - INBX
39%
Loosely correlated
-17.99%
ACET - INBX
39%
Loosely correlated
-0.49%
More